Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
50%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (50.0%)
N/A2 (50.0%)

Trials by Status

unknown250%
recruiting125%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
unknownnot_applicable

DNA Damage and Subfertility in Males - Lifestyle Interventions to Improve Male Fertility and Health

NCT04183374
unknownnot_applicable

COaching Lifestyle Intervention for FErtility

NCT04589793
recruitingphase_3

Impact of P53 and SIRT1 in Type 2 Diabetes

NCT03925714
completedphase_3

The Ebeltoft Health Promotion Project

NCT00145782

Clinical Trials (4)

Showing 4 of 4 trials
NCT04183374Not Applicable

DNA Damage and Subfertility in Males - Lifestyle Interventions to Improve Male Fertility and Health

Unknown
NCT04589793Not Applicable

COaching Lifestyle Intervention for FErtility

Unknown
NCT03925714Phase 3

Impact of P53 and SIRT1 in Type 2 Diabetes

Recruiting
NCT00145782Phase 3

The Ebeltoft Health Promotion Project

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4